Spyre Therapeutics, Inc. (SYRE): 144 filed Jul 1, 2026

Form type

144

Filing date

Jul 1, 2026

Accession number

0001950047-26-006779

Filer

Spyre Therapeutics, Inc. (CIK 1636282)